People · Operator
Named in public records as an officer, director or promoter · active 2017–2025 · Biotechnology, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pathos AI, Inc. | — | Biotechnology | Series D+ | $365.0M | $2.4B | 2023 |
| Tempus Labs, Inc. | — | Software / Tech | Series D+ | $271.0M | $178.9M | 2017 |
Ryan Fukushima at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ryan Fukushima on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Eric Lefkofsky | 2 | 8 |
| Brad Keywell | 1 | 12 |
| Peter Barris | 1 | 11 |
| Mohamad Makhzoumi | 1 | 10 |
| Tyrell Rivers | 1 | 6 |
| Ted Leonsis | 1 | 5 |
| Amit Mehta | 1 | 4 |
| Scott Gottlieb | 1 | 3 |
| JIM ROGERS | 1 | 2 |
| Eric Lefkofky | 1 | 1 |
| ROBERT GHENCHEV | 1 | 1 |
| Andrew Heinlein | 1 | 1 |
| WAYNE FREDERICK | 1 | 1 |
| ERIK PHELPS | 1 | 1 |
| ERIC BELCHER | 1 | 1 |
| NADJA WEST | 1 | 1 |
| JENNIFER DOUDNA | 1 | 1 |
| Alex Dolan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.